Back to all studies
TerminatedNCT01928446

Lithium for Suicide prevention in Mood Disorders

This study has public registry information. It focuses on suicide prevention and currently lists study information in the United States.

Suicidality, Depression, ...Drug

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Lithium may be useful for people experiencing suicide prevention.

What would participation involve?

Participants may receive Lithium, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for people with suicide prevention.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: July 8, 2015
Recruitment status
Terminated
Enrollment listed in the registry
519
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT01928446
Official title
CSP #590 - Lithium for Suicidal Behavior in Mood Disorders

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01928446. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 28 sites
  • Phoenix VA Health Care System, Phoenix, AZ
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • Southern Arizona VA Health Care System, Tucson, AZ
    Tucson, Arizona
    Site status: Not listed — confirm with the team
  • Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
    North Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • VA Loma Linda Healthcare System, Loma Linda, CA
    Loma Linda, California
    Site status: Not listed — confirm with the team
  • VA Palo Alto Health Care System, Palo Alto, CA
    Palo Alto, California
    Site status: Not listed — confirm with the team
  • VA San Diego Healthcare System, San Diego, CA
    San Diego, California
    Site status: Not listed — confirm with the team
  • VA Eastern Colorado Health Care System, Denver, CO
    Denver, Colorado
    Site status: Not listed — confirm with the team
  • Miami VA Healthcare System, Miami, FL
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Orlando VA Medical Center, Orlando, FL
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Atlanta VA Medical and Rehab Center, Decatur, GA
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Edward Hines Jr. VA Hospital, Hines, IL
    Hines, Illinois
    Site status: Not listed — confirm with the team
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN
    Indianapolis, Indiana
    Site status: Not listed — confirm with the team
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Minneapolis VA Health Care System, Minneapolis, MN
    Minneapolis, Minnesota
    Site status: Not listed — confirm with the team
  • VA Southern Nevada Healthcare System, North Las Vegas, NV
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • VA Sierra Nevada Health Care System, Reno, NV
    Reno, Nevada
    Site status: Not listed — confirm with the team
  • Asheville VA Medical Center, Asheville, NC
    Asheville, North Carolina
    Site status: Not listed — confirm with the team
  • Louis Stokes VA Medical Center, Cleveland, OH
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
    Pittsburgh, Pennsylvania
    Site status: Not listed — confirm with the team
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Michael E. DeBakey VA Medical Center, Houston, TX
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Central Texas Veterans Health Care System, Temple, TX
    Temple, Texas
    Site status: Not listed — confirm with the team
  • VA Salt Lake City Health Care System, Salt Lake City, UT
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA
    Seattle, Washington
    Site status: Not listed — confirm with the team
  • William S. Middleton Memorial Veterans Hospital, Madison, WI
    Madison, Wisconsin
    Site status: Not listed — confirm with the team
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI
    Milwaukee, Wisconsin
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with suicide prevention. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lithium, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with suicide prevention. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by VA Office of Research and Development, which appears to be a government agency. Sponsor website: https://www.research.va.gov. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me